CD40 and myeloid sarcoma: Also, when monocytes were stimulated with lipopolysaccharide (LPS) in vitro, it was shown that MS patients' monocytes had considerably greater levels of CD40 expression than healthy controls, suggesting that MS patients' monocytes are potentially more effective in co-stimulating T-cell activation than healthy controls [188].